COSMIC, chemotherapy plus ofatumumab at standard or mega-dose in chronic lymphocytic leukaemia, a phase II randomised study

Metadata

Authors/Creators:	Allsup, D Howard, D Emmerson, J https://orcid.org/0000-0002-8198-8043 Hockaday, A Rawstron, A Oughton, JB https://orcid.org/0000-0002-2047-804X Bloor, A Phillips, D Nathwani, A Paneesha, S Turner, D Munir, T Hillmen, P https://orcid.org/0000-0001-5617-4403
Keywords:	chronic lymphocytic leukaemia; chemotherapy; clinical trial; monoclonal antibody; minimal residual disease
Dates:	Accepted: 9 April 2021 Published (online): 24 May 2021
Institution:	The University of Leeds
Depositing User:	Symplectic Publications
Date Deposited:	08 Jun 2021 15:05
Last Modified:	08 Jun 2021 15:05
Status:	Published online
Publisher:	Wiley
Identification Number:	https://doi.org/10.1111/bjh.17526
Related URLs:	Author

CORE (COnnecting REpositories)